Lisa M. Butler

Has grant

University of Adelaide
Country flagAustralia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Novel co-extinction strategies for treatment of prostate cancer

Open Date: 2018-01-01

Close Date: 2020-01-01

Grant: Close

Lipid screening for prostate cancer prognosis

Open Date: 2018-01-01

Close Date: 2020-01-01

Grant: Close

Next-generation prostate cancer therapies based on precision nanomedicines

Open Date: 2017-01-01

Close Date: 2018-01-01

Grant: Close

A pharmacodynamic study of the heat shock protein 90 (Hsp90) inhibitor, AUY922, in high-risk, localised prostate cancer

Open Date: 2016-01-01

Close Date: 2019-01-01

Grant: Close

Exploiting alterations in lipid metabolism to improve diagnosis, treatment and molecular imaging of prostate cancer (ID MRTA3)

Open Date: 2015-01-01

Close Date: 2020-01-01

Articles (6)

Year:

2023

Year:

2022

Year:

2022

Cancer cells feature increased macromolecular biosynthesis to support the formation of new organelles and membranes for cell division. In particular, lipids are key macromolecules that comprise cellular membrane components, substrates for energy generation and mediators of inter- and intracellular signaling. The emergence of more sensitive and accurate technology for profiling the “lipidome” of cancer cells has led to unprecedented leaps in understanding the complexity of cancer metabolism, but also highlighted promising therapeutic vulnerabilities. Notably, fatty acids, as lipid building blocks, are critical players in all stages of cancer development and progression and the importance of fatty acid desaturation and its impact on cancer cell biology has been well established. Recent years have seen the reports of new mechanistic insights into the role of monounsaturated fatty acids (MUFA) in cancer, as regulators of cell death and lipid-related cellular signaling. This commentary aims to highlight these diverse roles of MUFAs in cancer cells which may yield new directions for therapeutic interventions involving these important fatty acids.

Year:

2022

Year:

2022

Year:

2020

Collaborators (21)

Robert Brooks

University of South Australia

AUSTRALIA
View details

sharon o toole

Trinity College Dublin

IRELAND
View details

David Lynn

Professor

Flinders University School of Medicine

AUSTRALIA
View details

Sonja Klebe

Flinders University

AUSTRALIA
View details

Courtney Moore

University of South Australia

AUSTRALIA
View details

Alison Zhang

Macquarie University

AUSTRALIA
View details

Ashley M Hopkins

-

AUSTRALIA
View details

Marten F. Snel

University of Adelaide

AUSTRALIA
View details

Anthony M. Joshua

University Health Network

CANADA
View details

Sarita Prabhakaran

Flinders University

AUSTRALIA
View details

Jessica Marie Logan

University of South Australia

AUSTRALIA
View details

Shadrack Mutuku

University of Wollongong

AUSTRALIA
View details

Benjamin Ung

University of South Australia

AUSTRALIA
View details

Andrew Hoy

Associate Professor

University of Sydney

AUSTRALIA
View details

Michael Sorich

Flinders University

AUSTRALIA
View details

Doug Brooks

Professor of Molecular Medicine

University of South Australia

AUSTRALIA
View details

Stavros Selemidis

RMIT University

AUSTRALIA
View details

Tahlia Scheinberg

Garvan Institute of Medical Research

AUSTRALIA
View details

Johannes Swinnen

Professor

KU Leuven

BELGIUM
View details

John O'Leary

Professor of Pathology and Head of Department

Trinity College Dublin

IRELAND
View details

Ian Johnson

University of South Australia

AUSTRALIA
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.